Levin Capital Strategies’s ARS Pharmaceuticals SPRY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $5.05M | Sell |
|
|||||
|
2025
Q1 | $14.7M | Buy |
|
|||||
|
2024
Q4 | $4.93M | Buy |
|
|||||
|
2024
Q3 | $3.91M | Buy |
|
|||||
|
2024
Q2 | $708K | Buy |
|
|||||
|
2024
Q1 | $565K | Buy |
|
|||||
|
2023
Q4 | $286K | Sell |
|
|||||
|
2023
Q3 | $242K | Sell |
|
|||||
|
2023
Q2 | $1.13M | Buy |
|
|||||
|
2023
Q1 | $914K | Buy |
|
|||||
|
2022
Q4 | $333K | Buy |
|